Time to calcitonin normalization after surgery for node‐negative and node‐positive medullary thyroid cancer.
Published: 6th February 2019
Authors: A. Machens, K. Lorenz, H. Dralle
It remains unclear when postoperative serum calcitonin levels should be measured in patients with medullary thyroid cancer (MTC) and, specifically, whether this decision should be based on the preoperative calcitonin level or nodal status.
A cohort of patients with previously untreated MTC was studied. Kaplan–Meier analyses, stratified by preoperative calcitonin level, nodal status and number of nodal metastases, were performed to determine time to calcitonin normalization after initial surgery, with statistical analysis by means of the log rank test.
Some 213 patients with node‐negative and 182 with node‐positive MTC were included in the study. Postoperative calcitonin levels normalized in a mean of 3·5 versus 3·7 days respectively among patients with preoperative calcitonin levels of 10–100 pg/ml (P = 0·815); 4·8 versus 5·3 days in those with preoperative calcitonin levels of 100·1–500 pg/ml (P = 0·026); 5·3 versus 9·9 days in patients with preoperative calcitonin levels of 500·1–1000 pg/ml (P = 0·004); and 6·6 versus 57·7 days among those with preoperative calcitonin levels exceeding 1000 pg/ml (P < 0·001). Calcitonin levels normalized in a mean of 4·7 days when nodal metastasis was not present, 5·2 days in those with one to five nodal metastases, 7·0 days in patients with six to ten nodal metastases, and 57·1 days among patients with more than ten nodal metastases. Postoperative calcitonin normalization curves paralleled each other in patients with node‐negative MTC, but diverged in those with node‐positive disease and with more nodal metastases.
Calcitonin levels typically normalize within 1 week; and within a fortnight in those with node‐positive MTC and preoperative calcitonin levels of 500·1–1000 pg/ml. With node‐positive MTC and preoperative calcitonin levels exceeding 1000 pg/ml, and with more than ten nodal metastases, calcitonin normalization takes longer.Full text
You may also be interested in
Authors: R. Miller, J. C. R. Wormald, R. G. Wade, D. P. Collins
Contralateral surgery in patients scheduled for total thyroidectomy with initial loss or absence of signal during neural monitoring.
Authors: A. Sitges‐Serra, L. Gallego‐Otaegui, J. Fontané, L. Trillo, L. Lorente‐Poch, J. Sancho et al.
Authors: L. M. Almond, F. Tirotta, H. Tattersall, J. Hodson, T. Cascella, M. Barisella et al.
Notes: Weak for liposarcoma
Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death. BJS 2019; 106: 174-180.
Authors: I. M. Shapey, A. Summers, T. Augustine, D. van Dellen
Systematic review of the use of big data to improve surgery in low‐ and middle‐income countries. BJS 2019; 106: e62-e72.
Authors: S. R. Knight, R. Ots, M. Maimbo, T. M. Drake, C. J. Fairfield, E. M. Harrison et al.
Surgical training programmes in the South Pacific, Papua New Guinea and Timor Leste. BJS 2019; 106: e53-e61.
Authors: D. A. Watters, E. McCaig, S. Nagra, I. Kevau
Authors: A. Wladis, N. Roy, J. Löfgren
Prevalence and predictors of surgical‐site infection after caesarean section at a rural district hospital in Rwanda. BJS 2019; 106: e121-e128.
Authors: T. Nkurunziza, F. Kateera, K. Sonderman, M. Gruendl, E. Nihiwacu, B. Ramadhan et al.
Authors: K. R. Iverson, K. Garringer, O. Ahearn, S. Alidina, I. Citron, S. Esseye et al.
Notes: Much to be done still
Evaluation of a surgical training programme for clinical officers in Malawi. BJS 2019; 106: e156-e165.
Authors: J. Gajewski, E. Borgstein, L. Bijlmakers, G. Mwapasa, Z. Aljohani, C. Pittalis et al.